KR vs REGN · P/E 19, rev $147.12B vs P/E 14, rev $14.34B
Kroger Company (KR) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Kroger Company (KR) is a grocery stores company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported KR revenue for 2025-02-01 was $147.12B. Net income was $2.67B. KR currently screens at market cap $46.17B and trailing P/E 19.0.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
KR currently screens at market cap $46.17B and trailing P/E 19.0. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the KR and REGN stock pages for the full models.
Not investment advice.